Axelrad TW, Steen B, Lowenberg DW, Creevy WR, Einhorn TA. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br. 2008;90-B(12):1617-1622. doi:10.1302/0301-620X.90B12.20975
Axelrad, T. W., et al. “Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients.”
The Journal of Bone & Joint Surgery British Volume, vol. 90-B, no. 12, 2008, pp. 1617-1622.,
https://doi.org/10.1302/0301-620X.90B12.20975
Axelrad, T. W., Steen, B., Lowenberg, D. W., Creevy, W. R., & Einhorn, T. A. (2008). Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients.
The Journal of Bone & Joint Surgery British Volume,
90-B(12), 1617-1622.
https://doi.org/10.1302/0301-620X.90B12.20975
Axelrad, T. W., Steen, B., Lowenberg, D. W., Creevy, W. R. and Einhorn, T. A. (2008) “Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients.”
The Journal of Bone & Joint Surgery British Volume, 90-B(12), pp. 1617-1622. Available at:
https://doi.org/10.1302/0301-620X.90B12.20975
Axelrad, T. W., B. Steen, D. W. Lowenberg, W. R. Creevy, and T. A. Einhorn. “Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients.”
The Journal of Bone & Joint Surgery British Volume 90-B, no. 12 (2008): 1617-1622.
https://doi.org/10.1302/0301-620X.90B12.20975
Axelrad TW, Steen B, Lowenberg DW, Creevy WR, Einhorn TA. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br. 2008 Dec 1;90-B(12):1617-1622.
https://doi.org/10.1302/0301-620X.90B12.20975
